295 related articles for article (PubMed ID: 6888237)
1. [Intravenous rifampicin therapy in open tuberculosis].
Loos U; Musch E; Mackes KG; Reetz KP; Gläser R; Schwabe HK; Hengstmann J; Eichelbaum M
Med Welt; 1983 Jun; 34(24):701-3. PubMed ID: 6888237
[No Abstract] [Full Text] [Related]
2. [Results of treatment of newly detected pulmonary tuberculosis with rifampin combined with isoniazid and ethambutol].
Szymański A; Walecki J; Czaplińska-Jóźwiak E; Kuczborska Z; Gaik A; Bilczak Z; Swiatnicka I; Swica T; Zdawski T
Pneumonol Pol; 1980 Nov; 48(11):669-74. PubMed ID: 7255207
[No Abstract] [Full Text] [Related]
3. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
[No Abstract] [Full Text] [Related]
4. [Remote results of short-term treatment of pulmonary tuberculosis with a combination of isoniazid, rifampin and ethambutol].
Sosnowski W; Krawczyk Z; Górnicka-Wilczyńska M; Pilarska-Machowicz A; Pruszyńska S; Pawlik J; Wardowa A; Woźniak B; Tomaszkiewicz L
Pneumonol Pol; 1980 Nov; 48(11):663-8. PubMed ID: 7255206
[No Abstract] [Full Text] [Related]
5. Simplified short-course treatment of pulmonary tuberculosis: experience with a regimen of ethambutol, rifampicin and isoniazid for 2 months followed by isoniazid or rifampicin for 4 months.
Gonzalez Montaner LJ; Leston JM; Cetrangolo A; Szemzo J; Calvete C; Dambrosi A; Mosca C
Bull Int Union Tuberc; 1976; 51(1):87-9. PubMed ID: 1030316
[No Abstract] [Full Text] [Related]
6. Controlled therapeutic trial with the combination rifampicin-isoniazid given for six months to previously untreated patients with pulmonary tuberculosis.
Dubra F
Bull Int Union Tuberc; 1972 Feb; 47():37-40. PubMed ID: 4562016
[No Abstract] [Full Text] [Related]
7. [Intermittent chemotherapy of pulmonary tuberculosis with rifampicin and ethambutol].
Virsik K; Kruty R; Matula F; Badalik L
Probl Tuberk; 1978 Oct; (10):28-30. PubMed ID: 714902
[No Abstract] [Full Text] [Related]
8. [Long term results of short course chemotherapy in pulmonary tuberculosis--(1st study):twelve- and eighteen-month chemotherapy with rifampicin-isoniazid and ethambutol].
Baba H; Schinkai A; Izuchi R; Azuma Y
Kekkaku; 1986 Jul; 61(7):371-7. PubMed ID: 3761792
[No Abstract] [Full Text] [Related]
9. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
Oka S; Sasaki M; Kobayashi T; Matsuda T
Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627
[No Abstract] [Full Text] [Related]
10. [Significance of the acetylator phenotype and initial oral/intravenous rifampicin administration in the treatment of tuberculosis].
Loos U; Musch E; Schwabe HK
Pneumologie; 1990 Feb; 44 Suppl 1():488-9. PubMed ID: 2367445
[TBL] [Abstract][Full Text] [Related]
11. [Results of 6-month and 9-month treatments with rifampin, isoniazid and ethambutol in cases of newly detected tuberculosis].
Szymanski A; Gaik A
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(3):181-3. PubMed ID: 6273991
[No Abstract] [Full Text] [Related]
12. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
[TBL] [Abstract][Full Text] [Related]
13. [Complex treatment of patients with destructive pulmonary tuberculosis including intramuscular administration of isoniazid].
Kalankhodzhaev AA; Gamzaeva NF
Probl Tuberk; 1991; (5):21-2. PubMed ID: 1924235
[TBL] [Abstract][Full Text] [Related]
14. [Treatment efficacy in destructive forms of pulmonary tuberculosis in relation to the methods of administering rifadin and isoniazid].
Shevchenko RN; German AK; Akhtyrskiĭ AI; Smirnova VV
Vrach Delo; 1989 Jun; (6):76-8. PubMed ID: 2781771
[TBL] [Abstract][Full Text] [Related]
15. [Dynamics of specific changes in recurrences of pulmonary tuberculosis in relation to chemotherapy schedules].
Bobarykin VS
Probl Tuberk; 1991; (10):53-5. PubMed ID: 1788233
[No Abstract] [Full Text] [Related]
16. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
Konno K; Oizumi K; Yamada S; Ogata K; Sato M
Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
[No Abstract] [Full Text] [Related]
17. [Short-course chemotherapy for pulmonary tuberculosis. 1. Clinical effect of RFP, INH and EB regimen for 9 months in the original treatment for pulmonary tuberculosis (author's transl)].
Oda T
Kekkaku; 1980 Jul; 55(7):331-9. PubMed ID: 7206413
[No Abstract] [Full Text] [Related]
18. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
[TBL] [Abstract][Full Text] [Related]
19. [Rifampicin and ethambutol treatment experience in chronic destructive pulmonary tuberculosis].
Petrova GN; Sedunova EA; Korotaeva TA
Probl Tuberk; 1981 Mar; (3):73-4. PubMed ID: 7232397
[No Abstract] [Full Text] [Related]
20. Serum concentration of isoniazid following administration of the drug alone and in combination with rifampicin in patients of pulmonary tuberculosis.
Singhal KC; Rathi R; Kishore K; Varshney SC; Varshney DP
Indian J Physiol Pharmacol; 1986; 30(1):115-7. PubMed ID: 3818028
[No Abstract] [Full Text] [Related]
[Next] [New Search]
